We are thankful to J. Tarara, J. Charlesworth, and Dr. M. Muders for their help with confocal microscopy, transmission electron microscopy, and TUNEL assay, respectively. We are also thankful to J. Lau for editorial assistance. This work was partly supported by NIH grants CA78383 and HL70567, a grant from the American Cancer Society to D.M., and a developmental grant from the Haem malignancy program at the Mayo Clinic (RAF-20P) and a CLL global foundation grant to P.M.. Partial support from UOFM-MEDICA#5CA and UOFM-MEDICA# 5P1, a grant from‘Minneasota Partnership for Translational Nanotechnology in Cancer' to D.M. and P.M., respectively, are also acknowledged. Supporting Information is available online from Wiley InterScience or from the author.
Pro-angiogenic Properties of Europium(III) Hydroxide Nanorods†
Article first published online: 29 JAN 2008
Copyright © 2008 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Volume 20, Issue 4, pages 753–756, February, 2008
How to Cite
Patra, C. R., Bhattacharya, R., Patra, S., Vlahakis, N. E., Gabashvili, A., Koltypin, Y., Gedanken, A., Mukherjee, P. and Mukhopadhyay, D. (2008), Pro-angiogenic Properties of Europium(III) Hydroxide Nanorods. Adv. Mater., 20: 753–756. doi: 10.1002/adma.200701611
- Issue published online: 15 FEB 2008
- Article first published online: 29 JAN 2008
- Manuscript Revised: 15 OCT 2007
- Manuscript Received: 4 JUL 2007
- NIH grants. Grant Numbers: CA78383, HL70567
- Endothelial cells;
- Nanorods, inorganic
Human umbilical vein endothelial cells (HUVECs) treated with europium(III) hydroxide nanorods (center figure) indicate the internalization of these nanorods to the cytoplasm of the cells. Chick chorioallantoic membrane (CAM) assay of HUVECS treated with the nanorods shows the formation of vascular sprouting, which supports in vivo angiogenesis.